172 related articles for article (PubMed ID: 24063558)
1. Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.
Li H; Wang J; Xu H; Xing R; Pan Y; Li W; Cui J; Zhang H; Lu Y
Mol Cancer; 2013 Sep; 12(1):110. PubMed ID: 24063558
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase 3a-induced hypermethylation of the fructose-1,6-bisphosphatase-2 promoter contributes to gastric carcinogenesis.
Huang Y; Lu H; Li H
Mol Biol Rep; 2024 Jan; 51(1):78. PubMed ID: 38183507
[TBL] [Abstract][Full Text] [Related]
3. Fructose-1,6-Bisphosphatase 2 Inhibits Oral Squamous Cell Carcinoma Tumorigenesis and Glucose Metabolism via Downregulation of c-Myc.
Wang L; Wang J; Shen Y; Zheng Z; Sun J
Oxid Med Cell Longev; 2022; 2022():6766787. PubMed ID: 35571245
[TBL] [Abstract][Full Text] [Related]
4. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
[TBL] [Abstract][Full Text] [Related]
5. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis.
Huangyang P; Li F; Lee P; Nissim I; Weljie AM; Mancuso A; Li B; Keith B; Yoon SS; Simon MC
Cell Metab; 2020 Jan; 31(1):174-188.e7. PubMed ID: 31761563
[TBL] [Abstract][Full Text] [Related]
6. Fructose bisphosphatase 2 overexpression increases glucose uptake in skeletal muscle.
Bakshi I; Suryana E; Small L; Quek LE; Brandon AE; Turner N; Cooney GJ
J Endocrinol; 2018 May; 237(2):101-111. PubMed ID: 29507044
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphatase 2 represses cervical cancer progression via inhibiting aerobic glycolysis through promoting pyruvate kinase isozyme type M2 ubiquitination.
Wang B; Yuan Y; Zou Y; Qi Z; Huang G; Liu Y; Xia S; Huang Y; Huang Z
Anticancer Drugs; 2022 Jan; 33(1):e198-e206. PubMed ID: 34387592
[TBL] [Abstract][Full Text] [Related]
8. Free fatty acids induce the demethylation of the fructose 1,6-biphosphatase 2 gene promoter and potentiate its expression in hepatocytes.
Wang L; Liu M; Wu Y; Li X; Yin F; Yin L; Liu J
Food Funct; 2021 May; 12(9):4165-4175. PubMed ID: 33977939
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
[TBL] [Abstract][Full Text] [Related]
10. The Reverse Warburg Effect is Associated with Fbp2-Dependent Hif1α Regulation in Cancer Cells Stimulated by Fibroblasts.
Duda P; Janczara J; McCubrey JA; Gizak A; Rakus D
Cells; 2020 Jan; 9(1):. PubMed ID: 31947613
[TBL] [Abstract][Full Text] [Related]
11. The essential role of fructose-1,6-bisphosphatase 2 enzyme in thermal homeostasis upon cold stress.
Park HJ; Jang HR; Park SY; Kim YB; Lee HY; Choi CS
Exp Mol Med; 2020 Mar; 52(3):485-496. PubMed ID: 32203098
[TBL] [Abstract][Full Text] [Related]
12. Changes in quaternary structure of muscle fructose-1,6-bisphosphatase regulate affinity of the enzyme to mitochondria.
Pirog M; Gizak A; Rakus D
Int J Biochem Cell Biol; 2014 Mar; 48():55-9. PubMed ID: 24412565
[TBL] [Abstract][Full Text] [Related]
13. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
14. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.
Miao Y; Li Q; Sun G; Wang L; Zhang D; Xu H; Xu Z
Cancer Med; 2020 Oct; 9(19):7231-7243. PubMed ID: 32780563
[TBL] [Abstract][Full Text] [Related]
15. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Axis.
Wang H; Tang Y; Yang D; Zheng L
Pharmacology; 2019; 104(3-4):173-186. PubMed ID: 31280269
[TBL] [Abstract][Full Text] [Related]
18. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
19. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase D3 promotes gastric cancer development through p65/6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 activation of glycolysis.
Zhang J; Zhang Y; Wang J; Zhang S; Zhao Y; Ren H; Chu Y; Feng L; Wang C
Exp Cell Res; 2019 Jul; 380(2):188-197. PubMed ID: 31026442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
